Merck & Co., Inc. Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31)
Merck & Co., Inc. (MRK) reported Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) of $147.00 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Notes › Compensation Related Costs
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions · last filed 2017-02-28
- Merck & Co., Inc. employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for fiscal 2016 was $147.00M, a 34.86% increase from fiscal 2015.
- Merck & Co., Inc. employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for fiscal 2015 was $109.00M, a 46.04% decline from fiscal 2014.
- Merck & Co., Inc. employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for fiscal 2014 was $202.00M, a 188.57% increase from fiscal 2013.
- Merck & Co., Inc. employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for fiscal 2013 was $70.00M, a 13.58% decline from fiscal 2012.
| Period end | Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) 12 month |
|---|---|
| 2016-12-31 | $147.00M 10-K · filed 2017-02-28 |
| 2015-12-31 | $109.00M 10-K · filed 2017-02-28 |
| 2014-12-31 | $202.00M 10-K · filed 2017-02-28 |
| 2013-12-31 | $70.00M 10-K · filed 2016-02-26 |
| 2012-12-31 | $81.00M 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |